Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fungal lysozyme leverages the gut microbiota to curb DSS-induced colitis

1 Jan 2021

Abstract excerpt

Colitis is characterized by colonic inflammation and impaired gut health. Both features aggravate obesity and insulin resistance. Host defense peptides (HDPs) are key regulators of gut homeostasis and generally malfunctioning in above-mentioned conditions. We aimed here to improve bowel function in diet-induced obesity and chemically induced colitis through daily oral administration of lysozyme, a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Gut microbiota and health
Share to Probiotics and Fermented Foods

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34693864
DOI: 10.1080/19490976.2021.1988836

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fungal lysozyme leverages the gut microbiota to curb DSS-induced colitisPMID 34693864Read ↗

Akkermansia muciniphila: A key player in gut microbiota-based disease modulationSemantic proximity Read ↗

Mycobiome and Inflammatory Bowel Disease: Role in Disease Pathogenesis, Current Approaches and Novel Nutritional-based TherapiesSemantic proximity Read ↗

Microbiome- and Host Inflammasome-Targeting Inhibitor Nanoliogmers are Therapeutic in Murine Colitis ModelSemantic proximity Read ↗

Pretreatment with yeast derived complex dietary-polysaccharide leads to suppressed gut inflammation, altered microbiota composition and increased immune regulatory short-chain fatty acid production in C57BL/6 miceSemantic proximity Read ↗

Systemic exposure to bacterial amyloid curli alters the gut mucosal immune response and the microbiome, exacerbating Salmonella -induced arthritisSemantic proximity Read ↗

Akkermansia muciniphila exacerbates food allergy in fibre-deprived miceSemantic proximity Read ↗

Capilliposide A alleviates DSS-induced colitis by regulating the intestinal flora and its metabolites of originSemantic proximity Read ↗

Differential colitis susceptibility of Th1- and Th2-biased mice: A multi-omics approachSemantic proximity Read ↗

Microbiota in mesenteric adipose tissue from Crohn’s disease promote colitis in miceSemantic proximity Read ↗

Gut microbiota phospholipids regulate intestinal gene expression and can counteract the effects of antibiotic treatmentSemantic proximity Read ↗

Gut bacteria enriched in obese mice produce leucic acid to counter obesity through HCAR2Semantic proximity Read ↗

Akkermansia muciniphila Suppresses High-Fat Diet-Induced Obesity and Related Metabolic Disorders in BeaglesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.